Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

China flag China · Delayed Price · Currency is CNY
31.93
+0.38 (1.20%)
Mar 10, 2026, 3:00 PM CST
-20.55%
Market Cap 4.90B
Revenue (ttm) 3.18B
Net Income (ttm) 326.30M
Shares Out 153.40M
EPS (ttm) 2.16
PE Ratio 14.81
Forward PE n/a
Dividend 0.90 (2.85%)
Ex-Dividend Date Apr 30, 2025
Volume 813,707
Average Volume 1,576,529
Open 31.70
Previous Close 31.55
Day's Range 31.64 - 31.97
52-Week Range 31.03 - 48.14
Beta 0.41
RSI 37.13
Earnings Date Mar 21, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It provides medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China. [Read more]

Sector Healthcare
Founded 1993
Employees 2,345
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600976
Full Company Profile

Financial Performance

In 2024, SHA:600976's revenue was 3.50 billion, a decrease of -16.81% compared to the previous year's 4.21 billion. Earnings were 362.18 million, a decrease of -30.54%.

Financial Statements

News

There is no news available yet.